Gangliosides in human uveal melanoma metastatic process

International Journal of Cancer

Volumn 68, Issue 1, 1996, Pages 97-101

  Tardif, Manon ^a   Coulombe, Josée ^a   Soulières, Denis ^a   Rousseau, Alain P ^a   Pelletier, Guy ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; TUMOR ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIVER METASTASIS; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE; TUMOR GROWTH; UVEA MELANOMA;

ANIMALS; G(M3) GANGLIOSIDE; GANGLIOSIDES; HUMANS; LIVER NEOPLASMS; MELANOMA; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED; UVEAL NEOPLASMS;

EID: 0029853752     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960927)68:1<97::AID-IJC17>3.0.CO;2-3     Document Type: Article

References (22)

1. BERGELSON, L.D., DYATLOVITSKAYA, E.V., KLYUCHAREVA, T.E., KRYUKOVA, E.V., LEMENOVSKAY, A.F., MATVEEVA, V.A. and SINITSYNA, E.V., The role of glycosphingolipids in natural immunity. Gangliosides modulate the cytotoxicity of natural killer cells. Europ. J. Immunol., 19, 1979-1983 (1989).
2. CHERESH, D.A., HARPER, J.R., SCHULZ, G. and REISFELD, R.A., Localization of the gangliosides GD2 and GD3 in adhesion plaques and on the surface of human melanoma cells. Proc. nat. Acad. Sci. (Wash.), 81, 5767-5771 (1984).
3. COULOMBE, J. and PELLETIER, G., Gangliosides and organ-specific metastatic colonization. Int. J. Cancer, 53, 104-109 (1993).
4. FIDLER, I.J. and KRIPKE, M.L., Metastasis results from pre-existing variant cells within a malignant tumor. Science, 197, 893-895 (1977).
5. HAKOMORI, S., Bifunctional role of glycosphingolipids. Modulators for transmembrane signaling and mediators for cellular interactions. J. biol. Chem., 265, 18713-18716 (1990).
6. HAKOMORI, S. and KANAGI, R., Glycosphingolipids as tumor-associated and differentiation markers. J nat. Cancer Inst., 71, 231-251 (1983).
7. HANDGRETINGER, R., ANDERSON, K., LANG, P., DOPFER, R., KLINGEBIEL, T., SCHRAPPE, M., REULAND, P., GILLIES, S.D., REISFELD, R.A. and NIETHAMMER, D., A phase I study of human/mouse chimeric anti-ganglioside GD2 antibody ch14.18 in patients with neuroblastoma. Europ. J. Cancer, 31A, 261-267 (1995).
8. IRIE, R.F. and MORTON, D.L., Regression of cutaneous metastatic melanoma by intralesional injection with human monoclonal antibody to ganglioside GD2. Proc. nat. Acad. Sci. (Wash.), 83, 8694-8698 (1986).
9. KALISIAK, A., MINNITI, J.G., OOSTERWIJK, E., OLD, L.J. and SCHEINBERG, D.A., Neutral glycosphingolipid expression in B-cell neoplasms. Int. J. Cancer, 49, 837-845 (1991).
10. KOJIMA, N. and HAKOMORI, S.-I., Specific interaction between gangliotriaosylceramide (Gg3) and sialosyllactosylceramide (GM3) as a basis for specific cellular recognition between lymphoma and melanoma cells. J. biol. Chem., 264, 20159-20162 (1989).
11. KOJIMA, N. and HAKOMORI, S.-I., Cell adhesion, spreading and motility of GM3-expressing cells based on glycolipid-glycolipid interaction. J. biol. Chem., 266, 17552-17558 (1991).
12. KOJIMA, N., SHIOTA, M., SADAHIRA, Y., HANDA, K. and HAKOMORI, S.-I., Cell adhesion in a dynamic flow system as compared to static system: glycosphingolipid-glycosphingolipid interaction in the dynamic system predominates over lectin- or integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells. J. biol. Chem., 267, 17264-17270 (1992).
13. LADISCH, S. and GILLARD, B., A solvent partition for microscale ganglioside purification. Anal. Biochem., 146, 220-231 (1985).
14. LAFRENIÈRE, R. and ROSENBERG, S.A., A novel approach to the generation and identification of experimental hepatic metastases in a murine model. J. nat. Cancer Inst., 76, 309-315 (1986).
15. LEDEEN, R. and YU, R.K., Gangliosides structure isolation and analysis. Methods Enzymol., 83, 139-191 (1982).
16. LI, R. and LADISCH, S., Shedding of human neuroblastoma gangliosides. Biochim. biophys. Acta, 1083, 57-64 (1991).
17. SENN, H.-J., ORTH, M., FITZKE, E., WIELAND, H. and GEROK, W., Gangliosides in normal human serum. Concentration, pattern and transport by lipoproteins. Europ. J. Biochem., 181, 657-662 (1989).
18. SOULIÈRES, D., ROUSSEAU, A., DESCHÊNES, J., TREMBLAY, M., TARDIF, M. and PELLETIER, G., Characterization of gangliosides in human uveal melanoma cells. Int. J. Cancer, 49, 498-503 (1991).
19. SVENNERHOLM, L., Quantitative estimation of sialic acids: II. A colorimetric resorcinol-hydrochloric acid method. Biochem. biophys. Acta, 24, 604-611 (1957).
20. VADHAN-RAJ, S., CORDON-CARDO, C., CARSWELL, E., MINTZER, D., DANTIS, L., DUTEAU, C., TEMPLETON, M.A., OETTGEN, H.F., OLD, L.J. and HOUGHTON, A.N., Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: induction of inflammatory responses at tumor sites. J. clin. Oncol., 6, 1636-1648 (1988).
21. YOGEESWARAN, G., STEIN, B.S. and SEBASTIAN, H., Altered cell surface organization of gangliosides and sialylglycoproteins of mouse metastatic melanoma, variant lines selected in vivo for enhanced lung implantation. Cancer Res., 38, 1336-1344 (1978).
22. ZEBDA, N., PEDRON, S., REBBAA, A., PORTOUKALIAN, J. and BERTHIER-VERGNES, O., Deficiency of ganglioside biosynthesis in metastatic human melanoma cells: relevance of CMP-NeuAc:LacCer α2-3 sialyltransferase (GM3 synthase). FBBS Lett., 362, 161-164 (1995).